Browse by author
Lookup NU author(s): Professor Hermann Josef Vormoor
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
We report the clinical course of a 6.5-year-old boy with refractory auto-immune haemolytic anaemia. Due to failure of conventional immunosuppressive therapy, an autologous peripheral blood stem cell transplantation was performed. The conditioning regimen consisted of cyclophosphamide and anti-thymocyte globulin. The patient was reinfused with 2.6 x 10(6) CD34 positive selected, B- and T-cell-depleted peripheral blood stem cells per kg body weight. He showed a partial response with a reduced demand for red blood cell transfusions. However, due to persistence of the haemolytic process he was started on rituximab therapy on day +40 post-transplant. Following two doses of rituximab, the patient improved rapidly and developed a sustained complete response. After 10 months, haemolysis recurred and responded again to rituximab therapy without the necessity for red blood cell transfusions. 15 months after initial antibody treatment, however, the patient developed a second relapse which was now refractory to rituximab therapy although CD20+ B-lymphocytes were cleared from the peripheral blood. CONCLUSION: Our case report suggests that rituximab and autologous peripheral blood stem cell transplantation are important though not curative elements in the treatment of patients with severe auto-immune haemolytic anaemia who are refractory to conventional immunosuppressive therapy.
Author(s): Seeliger S, Baumann M, Mohr M, Jürgens H, Frosch M, Vormoor J
Publication type: Article
Publication status: Published
Journal: European Journal of Pediatrics
Year: 2001
Volume: 160
Issue: 8
Pages: 492-496
Print publication date: 01/08/2001
ISSN (print): 0340-6199
ISSN (electronic): 1432-1076
URL: http://dx.doi.org/10.1007/s004310100778
DOI: 10.1007/s004310100778
Notes: 0340-6199 (Print) Case Reports Journal Article
Altmetrics provided by Altmetric